Skip to main content

Baader Bank Aktiengesellschaft

Bank

Position in GILD — Gilead Sciences, Inc.

CIK 1542629 Unterschleissheim, 2M

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$1,512,289
+$352,731 QoQ
Shares Held
11,970
+43.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#923
of 2,266 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2022
CallValue
$0
CallShares
0
PutValue
$1,850,700
PutShares
30,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Baader Bank Aktiengesellschaft holds $38,581,797 across 9 Drug Manufacturers - General names. GILD ranks #6 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
11,970 $1,512,289

All Filings in GILD

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,512,289 11,970
2026-03-31 $1,159,558 8,320
2025-12-31 $858,320 6,993
2025-09-30 $1,196,913 10,783
2025-06-30 $1,293,520 11,667
2025-03-31 $1,469,871 13,118
2024-12-31 $1,001,660 10,844
2024-09-30 $294,781 3,516
2024-06-30 $566,169 8,252
2022-09-30 $1,850,700 30,000
2022-09-30 $548,670 8,894
2022-06-30 $264,794 4,284
2022-03-31 $118,900 2,000
2022-03-31 $7,654,782 128,760
2021-12-31 $9,349,263 128,760